Cary Street Partners’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.95M Buy
93,826
+1,114
+1% +$89.5K 0.17% 135
2026
Q1
$7.76M Buy
92,712
+1,414
+2% +$107K 0.19% 125
2025
Q4
$6.12M Buy
91,298
+554
+0.6% +$35.8K 0.15% 152
2025
Q3
$6.14M Buy
90,744
+1,020
+1% +$73.9K 0.16% 145
2025
Q2
$6.69M Sell
89,724
-482
-0.5% -$32.1K 0.19% 134
2025
Q1
$5.68M Buy
90,206
+15,448
+21% +$955K 0.18% 133
2024
Q4
$4.26M Buy
+74,758
New +$4.42M 0.14% 154

Other funds holding CTVA

Cary Street Partners's CTVA Position: Q2 2026 in Review

Cary Street Partners increased its Corteva (CTVA) stake by 1.2% in Q2 2026, buying an estimated $89.5K and bringing the position to 93,826 shares worth $7.95M. The position accounts for 0.17% of the portfolio, ranked #135.

Cary Street Partners first reported a position in CTVA in Q4 2024 and has held it in 7 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Cary Street Partners held 93,826 shares of Corteva worth $7.95M as of Q2 2026.
  • Cary Street Partners bought 1,114 Corteva shares in Q2 2026, an estimated $89.5K.
  • Corteva made up 0.17% of Cary Street Partners's portfolio in Q2 2026, its #135 holding.
  • Cary Street Partners first reported a position in Corteva in Q4 2024 and has held it in 7 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.